Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neuroectodermal Tumors, Primitive × Doxorubicin × 30 days × Clear all

Sponsor

Conditions

Lymphoma, Large B-Cell, Diffuse 12 Neoplasms 8 Burkitt Lymphoma 8 Sarcoma 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Lymphoma, Follicular 5 Endometrial Neoplasms 5 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 4 Lymphoma, Non-Hodgkin 4 Lymphoma 4 Recurrence 3 Ovarian Neoplasms 3 Neoplasm Metastasis 3 Lymphoma, B-Cell 3 Liposarcoma 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Leiomyosarcoma 3 Hodgkin Disease 3 Histiocytoma, Malignant Fibrous 3 Colorectal Neoplasms 3 Breast Neoplasms 3 Urinary Bladder Neoplasms 2 Sarcoma, Synovial 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Neuroblastoma 2 Lymphoproliferative Disorders 2 Lymphoma, T-Cell 2 Lymphoma, B-Cell, Marginal Zone 2 Leukemia, Biphenotypic, Acute 2

Interventions

Temozolomide 1 Standard of Care 1 Radiotherapy 1 Nivolumab 1 Eflornithine 1 Drug Therapy 1 Blood Specimen Collection 1 Automobiles 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡